|
[1]
|
Shimizu, I. and Minamino, T. (2016) Physiological and Pathological Cardiac Hypertrophy. Journal of Molecular and Cellular Cardiology, 97, 245-262. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Tuomainen, T. and Tavi, P. (2017) The Role of Cardiac Energy Metabolism in Cardiac Hypertrophy and Failure. Experimental Cell Research, 360, 12-18. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Berkin, K.E. and Ball, S.G. (2001) Essential Hypertension: The Heart and Hypertension. Heart, 86, 467-475. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Cordes, K.R. and Srivastava, D. (2009) MicroRNA Regulation of Cardiovascular Development. Circulation Research, 104, 724-732. [Google Scholar] [CrossRef]
|
|
[5]
|
Thum, T., et al. (2007) MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure. Circulation, 116, 258-267. [Google Scholar] [CrossRef]
|
|
[6]
|
Van Rooij, E., et al. (2006) A Signature Pattern of Stress-Responsive microRNAs That Can Evoke Cardiac Hypertrophy and Heart Failure. Proceedings of the National Academy of Sciences of the United States of America, 103, 18255-18260. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Zuo, X., et al. (2012) Nicorandil Prevents Right Ventricular Re-modeling by Inhibiting Apoptosis and Lowering Pressure Overload in Rats with Pulmonary Arterial Hypertension. PLoS ONE, 7, e44485. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Oliveiracarvalho, V., et al. (2013) MicroRNAs: New Players in Heart Failure. Molecular Biology Reports, 40, 2663- 2670. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Van Rooij, E., et al. (2008) Dysregulation of microRNAs after Myocardial Infarction Reveals a Role of miR-29 in Cardiac Fibrosis. Proceedings of the National Academy of Sciences of the United States of America, 105, 13027-13032. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Roncarati, R., et al. (2014) Circulating miR-29a, among Other Up-Regulated MicroRNAs, Is the Only Biomarker for Both Hypertrophy and Fibrosis in Patients with Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology, 63, 920-927. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Wu, Z., et al. (2013) The Inhibitory Role of Mir-29 in Growth of Breast Cancer Cells. Journal of Experimental & Clinical Cancer Research, 32, 98. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Wang, Y., et al. (2013) The Role of miRNA-29 Family in Cancer. European Journal of Cell Biology, 92, 123-128. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Cui, Y., et al. (2011) MiR-29a Inhibits Cell Proliferation and In-duces Cell Cycle Arrest through the Downregulation of p42.3 in Human Gastric Cancer. PLoS ONE, 6, e25872. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
宋洋柳. GATA4招募PCG蛋白介导miR-29a表达调控C2C12细胞增殖与分化的机制研究[D]: [硕士学位论文]. 郑州: 郑州大学, 2016.
|
|
[15]
|
招霞. PTEN-PI3K-PDK1-Akt信号通路对心脏发育和心脏功能作用的研究[D]: [博士学位论文]. 南京: 南京大学, 2012.
|
|
[16]
|
王晓. microRNA-29a在肝癌患者中的表达及对肝癌细胞增殖、迁移能力的研究[D]: [博士学位论文]. 郑州: 郑州大学, 2017.
|
|
[17]
|
王慧玲, 等. miR-29a调控HDAC4促肝癌细胞增殖和转移的机制研究[J]. 胃肠病学和肝病学杂志, 2017, 26(4): 381-385.
|
|
[18]
|
王慧玲, 等. miR-29a调控IRS1促进肝门部胆管癌细胞增殖的机制研究[J]. 胃肠病学和肝病学杂志, 2019, 28(4): 456-460.
|
|
[19]
|
Ramdas, V., et al. (2013) Canonical Transforming Growth Factor-Beta Signaling Regulates Disintegrin Metalloprotease Expression in Experimental Renal Fibrosis via miR-29. The American Journal of Pathology, 183, 1885-1896. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
李晓, 等. miR-29a调控心肌肥大的分子机制研究[J]. 现代中西医结合杂志, 2017, 26(13): 1379-1381+1385.
|
|
[21]
|
Yuan, J., et al. (2011) Polo-Box Domain Inhibitor Poloxin Ac-tivates the Spindle Assembly Checkpoint and Inhibits Tumor Growth in Vivo. The American Journal of Pathology, 179, 2091-2099. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Kobayashi, Y., et al. (2015) Phase I Trial of Volasertib, a Po-lo-Like Kinase Inhibitor, in Japanese Patients with Acute Myeloid Leukemia. Cancer Science, 106, 1590-1595. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Harris, P.S., et al. (2012) Polo-Like Kinase 1 (PLK1) Inhibition Suppresses Cell Growth and Enhances Radiation Sensitivity in Medulloblastoma Cells. BMC Cancer, 12, 80. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Zhang, N., et al. (2016) Cardiac Ankyrin Repeat Protein Attenuates Cardiomyocyte Apoptosis by Upregulation of Bcl-2 Expression. Biochimica et Biophysica Acta, 1863, 3040-3049. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Xiong, Y., et al. (2010) Effects of microRNA-29 on Apoptosis, Tumorigenicity, and Prognosis of Hepatocellular Carcinoma. Hepatology, 51, 836-845. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Jafarinejad-Farsangi, S., et al. (2015) MicroRNA-29a Induces Apoptosis via Increasing the Bax:Bcl-2 Ratio in Dermal Fibroblasts of Patients with Systemic Sclerosis. Autoimmunity, 48, 369-378. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Chaudhry, H.W., et al. (2004) Cyclin A2 Mediates Cardiomyocyte Mitosis in the Postmitotic Myocardium. The Journal of Biological Chemistry, 279, 35858-35866. [Google Scholar] [CrossRef]
|
|
[28]
|
Anversa, P. and Kajstura, J. (1998) Ventricular Myocytes Are Not Terminally Differentiated in the Adult Mammalian Heart. Circulation Research, 83, 1-14. [Google Scholar] [CrossRef]
|
|
[29]
|
Beltrami, A.P., et al. (2001) Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction. The New England Journal of Medicine, 344, 1750-1757. [Google Scholar] [CrossRef]
|
|
[30]
|
Brooks, G., et al. (1997) Expression and Activities of Cy-clins and Cyclin-Dependent Kinases in Developing Rat Ventricular Myocytes. Journal of Molecular and Cellular Car-diology, 29, 2261-2271. [Google Scholar] [CrossRef] [PubMed]
|